The U.S. Food and Drug Administration (FDA) has announced serious risks associated with popular weight loss medications such as Ozempic and Munjaro. According to their findings, these drugs may lead to sudden vision loss.
Risks Associated with Medication Use
An analysis of 126 clinical studies revealed a potential increase in the risk of a rare condition affecting the blood supply to the optic nerve, which can result in:
- sudden vision loss;
- irreversible vision loss;
- the appearance of blind spots;
- changes in color perception.
While the FDA notes that a direct causal link between the medications and vision loss has not yet been established, the agency believes that the risks are serious enough to warrant a warning to users.
FDA Recommendations
In light of the identified risks, the FDA advises all patients taking these medications to be particularly vigilant about any changes in their vision. In the event of sudden vision deterioration or the appearance of any visual anomalies, individuals should seek medical attention immediately. This is a crucial step in preventing potential complications.